In a report released on March 14, Akash Tewari from Jefferies maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report), with a ...

Pharmaceutical company Eli Lilly (LLY) has been raking it in lately ... Thus it, along with Merck (MRK), got together to create the Young Institute Pharmaceutical Manufacturing Consortium.

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in ...

Eli Lilly has unveiled a $27 billion (€25.7 billion ... Last week, Ricks – alongside Merck’s chief executive Robert Davis, Pfizer head Albert Bourla and Stephen Ubl, who runs industry ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 71 trades. If we consider the specifics of each ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Manufacturing investments have taken center stage in ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of ...

Eli Lilly has unveiled a $27bn investment in US ... Last week, Ricks — alongside Merck’s chief executive Robert Davis, Pfizer head Albert Bourla and Stephen Ubl, who runs industry lobbying ...